Eko Foundation Analysis Software with Transformers (EFAST) vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

EFAST focuses on real-time AI analysis of auscultation data from digital stethoscopes to detect structural murmurs and atrial fibrillation. In contrast, the AI-ECG Tracker provides AI-powered auto-analysis and diagnosis of 12-lead ECG data for a comprehensive range of cardiac abnormalities. While both are FDA-cleared cardiology AI tools, they address different diagnostic inputs and stages of cardiac assessment.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered cardiac screening during routine physical examinations, particularly for early detection of structural murmurs and atrial fibrillation. This tool is ideal for clinicians seeking immediate, actionable insights directly from auscultation using integrated digital stethoscopes, streamlining point-of-care diagnostics.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your focus is on comprehensive and rapid AI-driven analysis of 12-lead ECG data for a wide array of cardiac abnormalities. This solution is best suited for cardiology or emergency medicine settings requiring detailed diagnostic support for conditions like arrhythmias, myocardial ischemia, and infarction, with the flexibility of on-premise processing and optional cloud services.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) AI-ECG Tracker
Pricing Subscription-based, contact for details Unknown
Deployment Cloud-based Software as a Medical Device (SaMD) Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A integrates AI directly into a familiar clinical workflow (auscultation with a smart stethoscope), offering real-time analysis and guided exams. This approach is likely more intuitive and less disruptive than Tool B's reliance on a separate workstation and client software for ECG analysis.

Clinical Value

AI-ECG Tracker

While Tool A provides high accuracy for specific conditions like structural murmurs and AFib, Tool B offers a broader diagnostic scope. It boasts high accuracy (over 95%) for a comprehensive range of 16 cardiac classifications and 104 ECG diagnostic classifications, including critical conditions like myocardial ischemia and infarction, providing greater overall clinical utility.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A is transparent about its subscription-based pricing model, including details like a yearly Eko+ membership and an approximate daily cost for its stethoscope technology. Tool B provides no publicly available pricing information, making it impossible to assess its value without direct inquiry.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with cloud-based deployment and EMR integration. Tool B's compliance is only stated as 'likely' for HIPAA and BAA, and its primary on-premise deployment might be less flexible for some enterprise environments, despite an optional cloud service.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A demonstrates significant innovation by transforming the traditional stethoscope into a smart, AI-powered diagnostic tool that provides real-time cardiac insights during routine physical exams. This integration of advanced AI into a fundamental, point-of-care diagnostic step represents a more disruptive approach to enhancing clinical workflow.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health (Tool A) offers a well-structured online Help Center with FAQs, user manuals, and multiple direct support channels including phone, email, scheduled calls, and live Q&A sessions. While Lepu Medical (Tool B) provides contact information and a download center for manuals, Tool A's support resources appear more consolidated and readily accessible to users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) AI-ECG Tracker
Product Name Eko Foundation Analysis Software with Transformers (EFAST) AI-ECG Tracker
Company Eko Health Shenzhen Carewell Electronics Co. (subsidiary of Lepu Medical)
Primary AI Function/Focus Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. Applies artificial intelligence technology to ECG auto-diagnosis.
Key AI Detections/Analysis AI-powered structural murmur detection, AI-powered atrial fibrillation (AFib) detection, Real-time AI analysis during auscultation, Enhanced audio with noise cancellation and amplification, Waveform visualization and guided exams. AI-powered ECG auto-analysis and diagnosis for common cardiac abnormalities including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; Supports 12-lead ECG data collection; Comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications.
Stated Accuracy Structural murmur detection (93% sensitivity, 91% specificity); Atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity). High accuracy (over 95%) for common cardiac abnormalities.
Supported Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation (AFib) during routine auscultation. The AI-ECG Tracker focuses on AI-powered auto-analysis and diagnosis of 12-lead ECG data for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
EFAST seamlessly integrates with Eko digital stethoscopes, such as the CORE 500, for real-time AI analysis during auscultation. The AI-ECG Tracker supports 12-lead ECG data collection, implying compatibility with standard 12-lead ECG devices.
EFAST is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA) available. For the AI-ECG Tracker, HIPAA compliance and the availability of a BAA are stated as 'likely,' given the company's operations in the US healthcare market and general privacy practices.
EFAST reports 93% sensitivity and 91% specificity for structural murmur detection, and 95% sensitivity and 94% specificity for AFib detection. The AI-ECG Tracker claims high accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
EFAST is designed for use in Cardiology, Family Medicine, and Internal Medicine. The AI-ECG Tracker is primarily aimed at Cardiology and Emergency Medicine specialties.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.